REGENLAB (EGF VD)
Signed · France, Italy
Source: European Investment Bank (EIB)
The project concerns developing, manufacturing and selling medical devices used for autologous cell therapies, particular in Platelet Rich Plasma (PRP) and autologous tissue engineering with Hyaluronic Acid (HA) in the field of orthopaedics and regenerative medicine. Recently, the company has developed a new model of its devices for the preparation of convalescent plasma (CP) - antibody-rich produ
- Status
- Under Construction
- Sector
- Hospital, Manufacturing (Industrial), Government
- Location
- France
- Updated
- 22 Jul 2026
- Source
- European Investment Bank (EIB)
ConstructChat
Ask ConstructChat about REGENLAB (EGF VD)
Pick a question to edit it, or write your own.
First answer free · no account
Project Information FAQ
Project Information
Participants
Sponsoring Agency |
Status
Original status | signed |
Taiyo status | Under Construction |
Taiyo last update | 2026-07-22 |
Contact
| Not available for this record. |
Description
Description | The project concerns developing, manufacturing and selling medical devices used for autologous cell therapies, particular in Platelet Rich Plasma (PRP) and autologous tissue engineering with Hyaluronic Acid (HA) in the field of orthopaedics and regenerative medicine. Recently, the company has developed a new model of its devices for the preparation of convalescent plasma (CP) - antibody-rich products that are collected from eligible donors who have recovered from COVID-19. |
Original sector | Services |
Location
Country | France |
Source
Source | European Investment Bank (EIB) |
URL |
More Details
Record type | Project |
Sector | Hospital, Manufacturing (Industrial), Government |
Article published date | 2025-07-28 |
Research
Free account
View all details
You are reading the public part. A free account opens the rest:
- Every detail on this project
- News and media coverage
- Technical research
Free account · no card · lands you back on this project
